{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:10:14Z","timestamp":1783555814360,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1016\/s1471-4914(03)00074-1","type":"journal-article","created":{"date-parts":[[2003,5,19]],"date-time":"2003-05-19T19:58:54Z","timestamp":1053374334000},"page":"244-250","source":"Crossref","is-referenced-by-count":80,"title":["Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor"],"prefix":"10.1016","volume":"9","author":[{"given":"Joyce","family":"Tombran-Tink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.","family":"Barnstable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S1471-4914(03)00074-1_BIB1","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0092-8674(00)81810-3","article-title":"Blood vessel formation: what is its molecular basis?","volume":"87","author":"Folkman","year":"1996","journal-title":"Cell"},{"key":"10.1016\/S1471-4914(03)00074-1_BIB2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0165-6147(02)02109-0","article-title":"Recent advances in angiogenesis, anti-angiogenesis and vascular targeting","volume":"23","author":"Bikfalvi","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1471-4914(02)02362-6","article-title":"PEDF: anti-angiogenic guardian of ocular function","volume":"8","author":"Bouck","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jcp.10026","article-title":"Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF","volume":"189","author":"Ohno-Matsui","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0002-9394(01)01008-X","article-title":"Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment","volume":"132","author":"Ogata","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB7","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.2337\/diabetes.50.12.2641","article-title":"Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease","volume":"50","author":"Spranger","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/S1471-4914(03)00074-1_BIB8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0002-9394(02)01406-X","article-title":"Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy","volume":"133","author":"Ogata","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0002-9394(02)01549-0","article-title":"Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration","volume":"134","author":"Holekamp","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0002-9394(02)01568-4","article-title":"Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy","volume":"134","author":"Ogata","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB11","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1523\/JNEUROSCI.15-07-04992.1995","article-title":"Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity","volume":"15","author":"Tombran-Tink","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.288.5466.665","article-title":"Extension of cell life-span and telomere length in animals cloned from senescent somatic cells","volume":"288","author":"Lanza","year":"2000","journal-title":"Science"},{"key":"10.1016\/S1471-4914(03)00074-1_BIB13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1242\/jcs.114.5.853","article-title":"The splice variants of vascular endothelial growth factor (VEGF) and their receptors","volume":"114","author":"Robinson","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB14","first-page":"23","article-title":"The emerging role of angiogenesis inhibitors in hematologic malignancies","volume":"16","author":"Giles","year":"2002","journal-title":"Oncology"},{"key":"10.1016\/S1471-4914(03)00074-1_BIB15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the quest for tumour angiogenesis factors","volume":"2","author":"Ferrara","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/S1471-4914(03)00074-1_BIB16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/107327480200902S05","article-title":"Clinical experience with angiogenesis signaling inhibitors:focus on vascular endothelial growth factor (VEGF) blockers","volume":"9","author":"Rosen","year":"2002","journal-title":"Cancer Control"},{"key":"10.1016\/S1471-4914(03)00074-1_BIB17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1517\/13543784.11.12.1715","article-title":"Therapies directed at vascular endothelial growth factor","volume":"11","author":"Manley","year":"2002","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/S1471-4914(03)00074-1_BIB18","first-page":"11","article-title":"Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin","volume":"2","author":"Tombran-Tink","year":"1996","journal-title":"Mol. Vis."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB19","doi-asserted-by":"crossref","first-page":"11131","DOI":"10.1073\/pnas.211268598","article-title":"Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor","volume":"98","author":"Simonovic","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB20","doi-asserted-by":"crossref","first-page":"9378","DOI":"10.1523\/JNEUROSCI.22-21-09378.2002","article-title":"Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons","volume":"22","author":"Bilak","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: a potent inhibitor of angiogenesis","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"key":"10.1016\/S1471-4914(03)00074-1_BIB22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/jpsu.2003.50104","article-title":"Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model","volume":"38","author":"Abramson","year":"2003","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcp.1114","article-title":"Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization","volume":"188","author":"Mori","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB24","first-page":"2428","article-title":"Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor","volume":"43","author":"Mori","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB25","doi-asserted-by":"crossref","first-page":"8909","DOI":"10.1073\/pnas.122247299","article-title":"Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1\u20133 of angiostatin reduce retinal neovascularization","volume":"99","author":"Raisler","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1006\/mthe.2002.0702","article-title":"Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents","volume":"6","author":"Auricchio","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB27","first-page":"1994","article-title":"AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization","volume":"43","author":"Mori","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-4835(91)90248-D","article-title":"PEDF: a pigment epithelium derived factor with potent neuronal differentiative activity","volume":"53","author":"Tombran-Tink","year":"1991","journal-title":"Exp. Eye Res."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB29","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1073\/pnas.90.4.1526","article-title":"Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family","volume":"90","author":"Steele","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/(SICI)1097-4547(19990915)57:6<789::AID-JNR4>3.0.CO;2-M","article-title":"Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death","volume":"57","author":"Cao","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB31","first-page":"1646","article-title":"In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor","volume":"42","author":"Cao","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/glia.1066","article-title":"Pigment epithelium-derived factor supports normal Muller cell development and glutamine synthetase expression after removal of the retinal pigment epithelium","volume":"35","author":"Jablonski","year":"2001","journal-title":"Glia"},{"key":"10.1016\/S1471-4914(03)00074-1_BIB33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1076\/ceyr.22.4.245.5506","article-title":"Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury","volume":"22","author":"Ogata","year":"2001","journal-title":"Curr. Eye Res."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB34","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1046\/j.1471-4159.1995.64062509.x","article-title":"Pigment epithelium-derived factor is a survival factor for cerebellar granule cells in culture","volume":"64","author":"Taniwaki","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB35","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/(SICI)1097-4547(19990615)56:6<604::AID-JNR6>3.0.CO;2-B","article-title":"Neuroprotection by pigment epithelial-derived factor against glutamate toxicity in developing primary hippocampal neurons","volume":"56","author":"DeCoster","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00005072-199907000-00006","article-title":"Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration","volume":"58","author":"Bilak","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB37","doi-asserted-by":"crossref","first-page":"31605","DOI":"10.1074\/jbc.274.44.31605","article-title":"Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons. Evidence for a PEDF receptor","volume":"274","author":"Alberdi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB38","doi-asserted-by":"crossref","first-page":"43313","DOI":"10.1074\/jbc.M107831200","article-title":"NF-\u03baB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons","volume":"276","author":"Yabe","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0006-291X(02)00548-X","article-title":"Pigment epithelium-derived factor exerts opposite effects on endothelial cells of different phenotypes","volume":"294","author":"Hutchings","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nm0402-349","article-title":"Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor","volume":"8","author":"Volpert","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB41","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1167\/iovs.02-0478","article-title":"The role of Fas\u2013FasL in the development and treatment of ischemic retinopathy","volume":"44","author":"Barreiro","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/S1471-4914(03)00074-1_BIB42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0960-9822(00)00512-1","article-title":"The caspase-8 inhibitor FLIP promotes activation of NF-\u03baB and Erk signaling pathways","volume":"10","author":"Kataoka","year":"2000","journal-title":"Curr. Biol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491403000741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491403000741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T04:00:37Z","timestamp":1623038437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491403000741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S1471491403000741"],"URL":"https:\/\/doi.org\/10.1016\/s1471-4914(03)00074-1","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}